RNXT logo
RNXT NASDAQ US

RenovoRx, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Aug 2021
$0.98
▲ +$0.01 (+1.03%)
Vol 130K
2
Quality Score
fail
Mkt Cap
$30.8M
ROE
-122.2%
Margin
-1196.7%
D/E
0.00
Beta
1.22
52W
$1–$2

Wall Street Consensus

10 analysts · Apr 2026
2
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating

Price Chart

Similar Stocks

CELU
Celularity Inc
$31.6M
CRVO
CervoMed Inc
$73.1M
NXTC
NextCure Inc
$49.7M
PDSB
PDS Biotechnology Corp
$42.1M
XLO
Xilio Therapeutics Inc
$33.6M
RNTX
Rein Therapeutics Inc
$30.5M
DYAI
Dyadic International Inc
$34.0M

Earnings

Beat rate: 80.0%
Next Report May 13, 2026
EPS Estimate: $-0.08
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.08 — —
Dec 2025 $-0.08 $-0.08 +$0.00
Sep 2025 $-0.08 $-0.08 +$0.00
Jun 2025 $-0.09 $-0.08 +$0.01

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -120.7% -119.6% -120.7% -120.7% -120.7% -122.2%
P/E (TTM) — — — — — —
Net Margin -686.0% — — — — -1196.7%
Gross Margin 64.0% — — — — 67.8%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 8.61 9.07 8.61 8.61 8.61 5.83

Key Ratios

ROA (TTM)
-90.7%
P/S (TTM)
33.18
P/B
6.9
EPS (TTM)
$-0.44
52W High
$1.69
52W Low
$0.70
$0.70 52-Week Range $1.69

How does RNXT compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

RNXT AAPG ABEO ABOS ABP

RNXT valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
33.2
▲ 158% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
6.9
▲ 181% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

RNXT profitability vs Biotechnology peers

ROE
-122.2%
▼ 82% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-1196.7%
▼ 317% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
67.8%
▼ 14% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-90.7%
▼ 94% below peers (-46.7%)
vs Peers
vs Industry
Weak

RNXT financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
5.8
▲ 31% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
1.2
▲ 26% above peers (1.0)
vs Peers
vs Industry
More volatile

RNXT fundamentals radar

RNXT Peer median Industry

RNXT profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

RNXT vs peers: key metrics

Latest News

No related news yet